Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis

Cytokine

Volumn 58, Issue 1, 2012, Pages 6-9

  Xiangyang, Zhu ^a   Lutian, Yao ^a   Lin, Zhao ^a   Liping, Xia ^a   Hui, Shen ^a   Jing, Lu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Disease activity score 28; Interleukin 33; Interstitial lung disease; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; INTERLEUKIN 33; RHEUMATOID FACTOR; STROMELYSIN;

ADULT; ARTICLE; BONE EROSION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE 28; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERLEUKIN 33 BLOOD LEVEL; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MATRIX METALLOPROTEINASE 3 BLOOD LEVEL; MODIFIED SHARP SCORE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BONE RESORPTION; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTERLEUKINS; LUNG DISEASES, INTERSTITIAL; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; PEPTIDES, CYCLIC; RHEUMATOID FACTOR;

EID: 84857447895     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.12.010     Document Type: Article

References (24)

1. Ulfgren A.K., Lindblad S., Klareskog L., Andersson J., Andersson U. Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 1995, 54(8):654-661.
2. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23(5):479-490.
3. Hayakawa H., Hayakawa M., Kume A., Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 2007, 282(36):26369-26380.
4. Funakoshi-Tago M., Tago K., Hayakawa M., Tominaga S., Ohshio T., Sonoda Y., et al. TRAF6 is a critical signal transducer in IL-33 signaling pathway. Cell Signal 2008, 20(9):1679-1686.
5. Kakkar R., Lee R.T. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 2008, 7(10):827-840.
6. Smith D.E. IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin Exp Allergy 2010, 40(2):200-208.
7. Prefontaine D., Lajoie-Kadoch S., Foley S., Audusseau S., Olivenstein R., Halayko A.J., et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 2009, 183(8):5094-5103.
8. Matsuyama Y., Okazaki H., Tamemoto H., Kimura H., Kamata Y., Nagatani K., et al. Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis. J Rheumatol 2010, 37(1):18-25.
9. Chapuis J., Hot D., Hansmannel F., Kerdraon O., Ferreira S., Hubans C., et al. Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry 2009, 14(11):1004-1016.
10. Oboki K., Ohno T., Kajiwara N., Saito H., Nakae S. IL-33 and IL-33 receptors in host defense and diseases. Allergol Int 2010, 59(2):143-160.
11. Verri W.A., Souto F.O., Vieira S.M., Almeida S.C., Fukada S.Y., Xu D., et al. IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann Rheum Dis 2010, 69(9):1697-1703.
12. Xu D., Jiang H.R., Kewin P., Li Y., Mu R., Fraser A.R., et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci U S A 2008, 105(31):10913-10918.
13. Palmer G., Talabot-Ayer D., Lamacchia C., Toy D., Seemayer C.A., Viatte S., et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum 2009, 60(3):738-749.
14. Carriere V., Roussel L., Ortega N., Lacorre D.A., Americh L., Aguilar L., et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A 2007, 104(1):282-287.
15. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31(3):315-324.
16. Prevoo M.L., van 't Hof M.A., Kuper H.H., Leeuwen M.A., van de Putte L.B., van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38(1):44-48.
17. van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 1999, 26(3):743-745.
18. Xu D., Jiang H.R., Li Y., Pushparaj P.N., Kurowska-Stolarska M., Leung B.P., et al. IL-33 exacerbates autoantibody-induced arthritis. J Immunol 2010, 184(5):2620-2626.
19. Mu R., Huang H.Q., Li Y.H., Li C., Ye H., Li Z.G. Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis. J Rheumatol 2010, 37(10):2006-2013.
20. Matsuyama Y., Okazaki H., Hoshino M., Onishi S., Kamata Y., Nagatani K., et al. Sustained elevation of interleukin-33 in sera and synovial fluids from patients with rheumatoid arthritis non-responsive to anti-tumor necrosis factor: possible association with persistent IL-1beta signaling and a poor clinical response. Rheumatol Int. 2011.
21. Ochkur S.I., Jacobsen E.A., Protheroe C.A., Biechele T.L., Pero R.S., McGarry M.P., et al. Coexpression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma. J Immunol 2007, 178(12):7879-7889.
22. Aliprantis A.O., Wang J., Fathman J.W., Lemaire R., Dorfman D.M., Lafyatis R., et al. Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Proc Natl Acad Sci U S A 2007, 104(8):2827-2830.
23. Komai-Koma M., Xu D., Li Y., McKenzie A.N., McInnes I.B., Liew F.Y. IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 2007, 37(10):2779-2786.
24. Chackerian A.A., Oldham E.R., Murphy E.E., Schmitz J., Pflanz S., Kastelein R.A. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 2007, 179(4):2551-2555.